Three-Statement Breakdown
REVENUE UP
Revenue rose 19% year over year to $3.5B, and carried a 5.2% net margin.
REVENUE
+19.4%
3,495
GROSS PROFIT
—
—
NET INCOME
+40.7%
181
EPS (DILUTED)
+45.8%
$1.91
| Income statement | 24-09 | 24-12 | 25-03 | 25-06 | 25-09 | 25-12 | 26-03 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,068 | 3,146 | 2,921 | 2,928 | 3,053 | 3,097 | 3,056 | 3,495 | +14.4% | +19.4% | |
| SG&A | (72) | (82) | (73) | (75) | (69) | (65) | (62) | (66) | +6.2% | -12.2% | |
| Operating income | 224 | 207 | 179 | 197 | 243 | 246 | 207 | 259 | +25.3% | +31.5% | |
| Interest expense | (21) | (22) | (19) | (21) | (18) | (17) | (18) | (17) | -6.3% | -21.2% | |
| Income tax | (51) | (36) | (42) | (47) | (54) | (52) | (48) | (62) | +29.5% | +30.2% | |
| Net income | 152 | 155 | 118 | 129 | 171 | 181 | 142 | 181 | +27.9% | +40.7% | |
| EPS (diluted) |
NOT DISCLOSED
10-Q
|
$1.49 | — | $1.17 | $1.31 | $1.76 | — | $1.49 | $1.91 | +28.2% | +45.8% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-24 ↗